Inflammatory Bowel Disease clinical trials at UC Irvine

4 in progress, 1 open to eligible people

Showing trials for

  • CDPATH™ to Help Manage and Treat Crohn's Disease

    open to eligible people ages 18 years and up

    CDPATH™ is a tool to help predict the potential for developing Crohn's disease related complications in certain adult participants within 3 years. The main aim of the study is to explore the use of CDPATH™ to describe a participant's risk profile and to have discussions with their doctor about the potential path of their Crohn's disease. The number of visits will be decided by the study clinic according to their standard practice.

    Orange, California and other locations

  • Mirikizumab (LY3074828) in Participants With Crohn's Disease

    Sorry, in progress, not accepting new patients

    The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

    Orange, California and other locations

  • Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

    Sorry, not currently recruiting here

    The purpose of this open-label extension (OLE) study is to evaluate the safety and efficacy of etrasimod in participants with moderately to severely active ulcerative colitis (UC) who previously received double-blind treatment (either etrasimod 2 mg per day or placebo) during participation in one of the qualified Phase 3 or Phase 2 double-blind, placebo-controlled parent studies including but not limited to: (APD334-301 [NCT03945188] or APD334-302 [NCT03996369] or APD334-210 [NCT04607837]).

    Irvine, California and other locations

  • Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis

    Sorry, in progress, not accepting new patients

    The purpose of this study is to determine whether oral etrasimod is a safe and effective treatment for moderately active ulcerative colitis in adult participants.

    Irvine, California and other locations

Our lead scientists for Inflammatory Bowel Disease research studies include .

Last updated: